Development of the state-of-the-art facility was made possible by a £2 million (US$2.6 million) round of funding, and a successful inspection by MHRA was completed in March 2025. The contract research ...

Significant increase in technical positions at BDD helping further strengthen Scotland's life sciences workforce Glasgow, Scotland, 8 April 2025 – Leading contract research company BDD has opened its ...

Breakthrough Device Designation (“BDD”) applies to an estimated U.S. population of over 7.7 million patients with uncontrolled hypertension and increased cardiovascular risk BDD also encompasses ...